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Simple Summary: Previous research supports the participation in supervised exercise among individuals with metastatic prostate cancer to help lessen the physical and psychological disease
burden. However, many individuals experience considerable barriers to attending face-to-face exercise services. To overcome some of these limitations, digital interventions that can be delivered
remotely have been proposed. Our pilot study investigated the acceptability, safety and preliminary
efficacy of an 8-week computer-tailored web-based exercise intervention. We demonstrated that
a web-based exercise program with telehealth support was acceptable and could be implemented
safely. Participants in the intervention group increased their participation in moderate to vigorous
physical activity compared to the control group. This study provides insight into the prospect of
web-based exercise prescription for individuals with metastatic prostate cancer as an alternative for
individuals who cannot access supervised exercise interventions.
Abstract: Preliminary research has shown the effectiveness of supervised exercise-based interventions
in alleviating sequela resulting from metastatic prostate cancer. However, many individuals encounter
barriers that limit the uptake of face-to-face exercise. Technology-enabled interventions offer a
distance-based alternative. This pilot study aimed to explore the acceptability, safety and preliminary
efficacy of a web-based exercise intervention (ExerciseGuide) in individuals with metastatic prostate
cancer. Forty participants (70.2 ± 8.5 years) with metastatic prostate cancer were randomised into
the 8-week intervention (N = 20) or a wait-list control (N = 20). The intervention arm had access to a
computer-tailored website, personalised exercise prescription and remote supervision. ExerciseGuide
was deemed acceptable with a score ≥20 on the client satisfaction questionnaire; however, the
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usability score was just below the pre-specified score of ≥68 on the software usability scale. There
were no serious adverse events reported. Moderate-to-vigorous physical activity levels between
baseline and follow-ups were significantly higher (10.0 min per day; 95% CI = (1.3–18.6); p = 0.01) in
the intervention group compared to wait-list control. There were also greater improvements in step
count (1332; 95% CI = (159–2505); p = 0.02) and identified motivation (0.4, 95% CI = (0.0, 0.7); p = 0.04).
Our findings provide preliminary evidence that ExerciseGuide is acceptable, safe and efficacious
among individuals with metastatic prostate cancer.
Keywords: exercise; metastatic prostate cancer; behavioural change; eHealth; computer-tailoring;
usability; acceptability; rct

1. Introduction
Prostate cancer is the second most common malignancy in Australia, with one in
six individuals diagnosed by the age of 85 [1]. Unlike individuals with localised prostate
cancer who have a 95% five-year survival, individuals whose cancer has metastasised to
secondary sites (bone, viscera and nodes) have an approximately 30% five-year survival
despite treatment [1].
Individuals with metastatic prostate cancer face substantial physical and psychological deterioration due to toxicities relating to life-prolonging therapies such as treatment
with abiraterone, enzalutamide, docetaxel, cabazitaxel, radium-223 and sipuleucel-T [2].
Furthermore, individuals deal with symptoms from the disease, such as pain and disability relating to metastasis, which are typically found in bone, liver and thorax [3]. These
negative changes create a vicious cycle of physical inactivity, which then accelerates their
physical decline [4]. It has been established that individuals with metastatic prostate cancer
have a desire to maintain sufficient physical and emotional functioning to maintain their
daily responsibilities (i.e., physical housework, hobbies and spending time with loved
ones); it is essential that their physical function and cardiorespiratory fitness is retained for
as long as possible in order to maximise quality of life [5].
Strong evidence supports tailored exercise prescription in individuals with metastatic
prostate cancer within supervised research settings [4,6,7]. Researchers have stated improved physical function, body strength, submaximal aerobic exercise capacity, ambulation,
lean mass and emotional well-being [8–10]. Although it is still unclear what effect a tailored
exercise program has on long term survival in this population, observational studies have
reported that increased physical activity is associated with a lower risk of cancer-specific
mortality in individuals with localised prostate cancer [11,12].
Despite the significant positive benefits observed, the gold-standard but resourceintensive model of tailored supervised exercise seen in research settings and exercise clinics
is unlikely to be accessible for all individuals. For example, Sheill et al. reported that
individuals with metastatic prostate cancer can face considerable financial, access and time
limitations, as well as treatment-related side effects that can impede supervised exercise
uptake and adherence in community settings [13]. Moreover, individuals within the Sheill
et al. study noted that lack of appropriate exercise-based facilities in rural areas was also a
notable barrier [13].
To address some of these barriers, technological advances, such as computer-tailored
websites (where content is personalised using algorithms), present alternative exercise prescription and education opportunities. In other oncology populations, web-based interventions have shown promising behaviour changes in diet and physical activity [14–16]. The
advantage of web-based technology lies in the added scalability, reach, cost-effectiveness
and accessibility [16]. No studies have focused on utilising detailed algorithms to tailor
both aerobic and resistance training prescriptions to individuals with metastatic prostate
cancer, but the opportunities to provide adaptive distance-based individualised exercise
prescription is especially valuable. Compared to individuals with localised disease, indi-
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viduals with metastatic prostate cancer often have bone lesions and other considerations
for exercise prescription, which increase the need for tailored programming to reduce risks.
The lab-based evidence of computer-tailored exercise prescription shows encouraging
acceptability, usability and safety levels in individuals with metastatic prostate cancer;
however, feasibility, safety and efficacy in a real-world setting is currently unknown [17].
To be effective in the real-world, some level of human contact is likely needed. Previous research suggests that having someone to be accountable to is important for adherence
to web-based programs, even when computer-tailoring is employed to personalise context [18]. A recent review of web-based programs supports this, with web-based programs
that incorporate human support found to have greater efficacy and adherence than those
that are standalone [19].
We undertook a pilot randomised controlled trial to assess the acceptability, safety
and preliminary efficacy of a computer-tailored web-based intervention (ExerciseGuide) in
combination with brief tele-support for enhancing exercise and health among individuals
with metastatic prostate cancer.
2. Materials and Methods
2.1. Trial Design
A randomised controlled pilot trial comprising two study arms, (1) an 8-week exercise
intervention arm (web-based tool and telehealth support) and (2) a wait-list control arm.
The study protocol, including criteria for progression to a larger definitive trial, was
published a priori [17]. Assessments are completed at baseline and in week nine. Ethics
approval was granted by the University of Adelaide Research Ethics Committee and two
South Australian Health Human Research Ethics Committees (Southern Adelaide Local
Health Network and Central Adelaide Local Health Network). The study was registered
on the Australian New Zealand Clinical Trials Registry (ACTRN12618001979246) and
reporting and conduct adhered to the Consolidating Standards of Reporting Clinical Trials
(CONSORT) guidelines [20]. Due to the nature of the study, it was not feasible to blind
participants. All participants provided written informed consent to participate before
entering the study.
The ExerciseGuide trial was conducted Australia-wide, with protocols described in
depth previously [21]. In short, mixed methods (questionnaires, accelerometry, qualitative
interviews and physical function testing) were used for acceptability, safety and efficacy
evaluation, with the success of the intervention interpreted based on the following criteria:
1.

Acceptability:
a.
b.

2.

Safety:
a.

3.

No grade 3+/life threatening, or severe adverse events resulted from participating in the intervention.

Efficacy:
a.

4.

The acceptability of the intervention was satisfactory (an average score of ≥20
on the client satisfaction questionnaire) [22].
The website usability was satisfactory (an average score of ≥68 on the software
usability scale) [23].

Evidence of clinically meaningful participation in either aerobic and or resistance exercise in the intervention group relative to the wait-list control, defined
as a between-group difference of at least 30 min of aerobic activity and or one
resistance training session per week.

Feasibility of conducting a larger-scale trial:
a.
b.
c.

The recruitment goal of 66 participants was reached.
Behaviour change data was collected for ≥75% of participants.
Physical functioning data was collected for ≥75% of participants that (a) reside
within 30 km from a study testing site and (b) are invited to complete testing.
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Additional measures of acceptability, safety and efficacy were also included and are
described in detail below.
2.2. Participants
One hundred and forty-one male patients with metastatic prostate cancer expressed
interest in the study from February 2020 to January 2021 and forty-one were deemed eligible
to participate. Participants met the inclusion criteria if they had a confirmed diagnosis
of metastatic prostate cancer and medical clearance to participate in the study from their
physician (i.e., General Practitioner, Medical Oncologist), which also detailed all metastasis
location/s and severity. Participants were required to be proficient in English, have access
to the internet and be free from contraindications to performing moderate intensity exercise
(i.e., no recent serious cardiovascular events within 12 months, unstable bone metastases,
spinal compressions or acute illnesses) [24].
Participants were excluded if they were deemed as currently sufficiently active, which
was defined as already engaging in two sessions of resistance training and 60 min of
structured moderate–vigorous aerobic exercise per week or had current moderate to severe
bone pain (Common Terminology Criteria for Adverse Events V.5.0 grading criteria).
2.3. Recruitment
Participants were recruited via social media advertisements (i.e., Facebook), Prostate
cancer and men’s health research volunteer registries (Prostate Cancer Foundation of Australia Pathfinders registry and The Freemasons Centre for Male Health and Wellbeing
registry), the South Australian Prostate Cancer Registry prostate cancer nurses, urologists
and medical oncologists. All potential participants were directed to the study webpage
(www.exerciseguide.org.au; accessed 23 November 2021). Detailed study information,
an automated screening tool and researchers’ contact details were found on the website.
Interested participants were encouraged to complete the automated web-based screening survey, and if assessed as potentially eligible, were asked to provide contact details.
Researchers then verified eligibility via a phone interview, and an information pack was
emailed or posted. Once written consent and medical clearance was returned, baseline
assessments were undertaken.
2.4. Randomisation
Participants were stratified by age (≤65 years, >65 years) and physical function
(physical functioning domain of the European Organisation for Research and Treatment of
Cancer (EORTC) quality of life questionnaire ≤80, >80). After the baseline assessments
were completed, participants were randomised into either the ExerciseGuide intervention
group or the wait-list control group using block randomization (block sizes of 2 and 4).
2.5. Intervention
2.5.1. ExerciseGuide Intervention
A detailed description of the ExerciseGuide intervention has been published previously [21]. Briefly, participants received access to a computer-tailored website (www.
exerciseguide.org.au; accessed 23 November 2021), which provided individualised multimodal exercise prescription via text and videos and behavioural change information for
eight weeks in the form of nine computer-tailored modules (see Figure 1). All modules
(with exception of the weekly tracking modules) were accessible all at once (free-choice
design) in order to promote autonomy and allow users to self-tailor usage according to
their interests. The weekly tracking module opened after the first seven days and once
completed the next tracking module opened seven days later. The modules were developed
from previous exercise oncology [7,8,25] and behavioural science studies [5,8,26], and were
guided by behavioural change theories [27–33]. The modules included:
1.
2.

Getting started (how to use the website and basics of the intervention);
My exercise plan 1 (tailored exercise programming for week 1–3);
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3.
4.
5.
6.
7.
8.
9.

My exercise plan 2 (progression/regression tailored exercise programming for week
4–8);
Exercise benefits (health benefits specific to metastatic prostate cancer);
Exercise safely (considerations necessary to remain safe whilst exercising);
Making it last (behavioural change information, including building confidence and
habits);
Exercise + (information on nutrition, distress, sedentary behaviours, sleep, etc.);
Where else can I get help? (Facilitate access to additional support);
How are you tracking? (Facilitate self-monitoring of exercise behaviours and exercise
outcomes).

a

b

c

d

Figure 1. Screenshots of the ExerciseGuide intervention: (a) the ExerciseGuide landing page, (b) the ExerciseGuide homepage,
(c) the My Exercise Plan 1 module (d) the Making it Last (behaviour change) module.

The ExerciseGuide website also contained a library, with short prostate cancer, exercise
or behaviour change articles, written in layman’s language and an “Ask the EP” (Exercise
Physiologist) feature of the website, where participants have the option of submitting
questions to the exercise physiologist.
Participants were provided with an individualised aerobic, resistance-based and
flexibility exercise prescription based on data they entered into the website in week one
and week three as described in depth in the study protocol [21]. Participants were also
able to regress or progress their prescription at any time by changing the answers to the
computer-tailoring questions within the module. The prescriptions were based upon
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exercise guidelines for cancer patients [25], and approaches used in previous studies for
managing bone lesions [8,9,34]. In short, the aerobic training prescription ranged from
2–3 sessions per week for 16–40 min (including rest breaks when prescribed). Regressions
and progressions were made by manipulating duration and mode. The resistance training
prescription ranged from 2–3 days per week and included 2–3 sets of 8–12 repetitions with
a focus of strength and hypertrophy. The program aimed to slowly increase session volume
until week six, where volume was reduced, and an emphasis was placed on increasing load
to maintain intensity. This change was prescribed to reduce the likelihood of participants
increasing repetition range past 12 repetitions as a method of progression, which would
likely extend session duration without significant improvements in strength. The OMNI
resistance and aerobic exercise scale of rate perceived exertion (RPE) was used to prescribe
intensity, which ranged from 6 to 7 out of 10. Participants were instructed to increase
or decrease the speed (aerobic training) or load (resistance training) of the exercises by
a subjective 5–10% if RPE scores did not match the prescribed OMNI scale [14]. Four
resistance exercise bands with variable levels of tension and a door anchor were supplied.
Participants with access to home-based or gym resistance training equipment were encouraged to replicate the exercises if the equipment was suitable. A paper-based exercise diary
was also provided to allow self-reporting and tracking of resistance exercises (exercises,
sets, repetitions, session RPE, duration, bone pain visual analogue score and general pain
visual analogue scale), aerobic exercises (type, duration, session rate of perceived exertion,
bone pain score and general pain scale) and stretching exercises performed.
Additionally, participants received two telehealth consultations (week 1 and 4) using
a videoconferencing platform such as Zoom [35], Skype [36] or phone calls. Consultation
mode was determined by participant preference. Within these sessions, behaviour change
considerations that included barriers and confidence were discussed, and participant’s
exercise prescription was reviewed and modified based on clinical judgement if required).
The consultations were conducted by HELE, who is an accredited exercise physiologist
with seven years of experience. In weeks 2–3 and 5–8, participants were contacted by
short message service (SMS) or email based on their preference to monitor compliance, aid
adherence and provide support when needed.
2.5.2. Wait-List Control Intervention
Participants in the wait-list control group received no specific instructions regarding
physical activity or access to equipment during the eight-week intervention. After followup outcome measures were assessed, the wait-list control group were offered the full
ExerciseGuide intervention and were also supplied resistance bands
2.6. Outcome Measure
Unless otherwise specified, outcome measures were assessed at baseline (0 weeks)
and at follow-up (week 9).
2.6.1. Acceptability
For the purposes of this trial, acceptability was viewed as a multi-faceted construct
related to user thoughts and feelings about the intervention. Several measures of acceptability were included, with priority given to facets that were thought to potentially
influence efficacy or future uptake [30,37]. All acceptability measures were assessed in
intervention participants only and only at follow-up, with the exception of star ratings and
comments [37] for modules, which were collected in real-time and were optional. For all
measures, higher scores indicate higher acceptability.
The client satisfaction questionnaire-8 (CSQ-8) was used to evaluate overall intervention satisfaction. Eight items were measured on a 4-point scale [22]. The cut-point of 20 was
chosen to designate satisfaction as it represents an average score of 2.5 on each item. The
perceived usability of the intervention website was evaluated using the System Usability

Cancers 2021, 13, 5925

7 of 22

Scale. A score above 68 is considered “above average” and was chosen as the cut-point for
success [23].
The perceived environmental supportiveness scale (15 items) was used to assess
perceptions of need support provided by ExerciseGuide [38]. The measure provides an
overall score and autonomy, structure and involvement subscale scores [38].
The extent to which the intervention was considered personally relevant was assessed
using three items (“the program was very relevant to me”, “the program was very applicable” and “the program seems like it was written for someone like me in mind”) on a
7-point scale ranging from strongly disagree to strongly agree.
Finally, three open-ended survey questions asking for feedback on the positives of the
program, constructive feedback and suggestions for improvement were used to understand
users’ perception [39].
2.6.2. Website Usage
Website usage was measured using the Google Analytics web traffic analysis platform
and built-in website tracking software [40].
2.6.3. Safety
Two methods assessed the safety of the exercise program. Participants were instructed
to report any adverse events in the study period to the study project coordinator (HELE).
Information collected included date event occurred, date reported and grade based on the
Common Terminology Criteria for Adverse Events V.5.0 grading criteria. An adverse events
item (“Do you feel that you have experienced any health issues as a result of participating
in this research study”) was also included within the follow-up questionnaire based on the
same criteria.
2.6.4. Efficacy
Behaviour Change–Physical Activity and Exercise
The ActiGraph GT3X activity monitor (Actigraph, Pensacola, FL, USA) was used to
objectively measure minutes of moderate to vigorous physical activity (MVPA) as well as
light physical activity and sedentary time minutes at baseline and follow-up. Participants
were mailed and asked to wear the devices on the right hip for seven days and only remove
during water-based activities and sleep [40]. The validity and reliability of the ActiGraph
GT3X has been established [41]. Triaxial data was recorded in 1-s epochs for at least 600 min
of wear time per day on at least five days within a seven-day period, and wear-time was
validated using Choi et al. [42]. The Godin leisure-time exercise questionnaire assessed
self-reported physical activity (average frequency and duration of mild, moderate and
vigorous aerobic exercise and total resistance training) at baseline and follow-up [43,44].
Adherence to the prescribed exercise program was assessed by auditing participant’s
exercise diaries, which included self-reported information on the frequency, intensity, time
and type of exercise completed. This was then cross-referenced with their individualised
prescription. Perceptions of adherence were also assessed using two items (“I have been
doing all of the aerobic [cardiovascular] exercises I was asked to by ExerciseGuide” and “I
have been doing all of resistance-based [strength] exercises I was asked to by ExerciseGuide”)
with an 11-point numeric rating scale (0 = strongly disagree, 10 = strongly agree) [45].
Patient-Reported Outcomes
The EORTC Quality of Life-Core 30 (EORTC QLQ-C30) measured health-related quality of life using a 30-item core survey [46]. Fatigue was assessed using the Functional
Assessment of Chronic Illness Therapy-fatigue subscale (13-items) [47]. The Hospital Anxiety and Depression Scale evaluated depression and anxiety (14-items), and the Pittsburgh
Sleep Quality Index questionnaire measured sleep quality [48–50]
Socio-cognitive determinants of physical activity (intervention mechanisms):
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Barrier self-efficacy (9 items) [51], outcome expectations (8 items) [52], motivation type
(19 items) [53], social support (2 items) [51], intentions (4 items) [54], behavioural capability
(3 items) [39] and habit formation (4 items) [31] were all assessed at baseline and follow-up.
Objective Measures of Physical Function and Muscular Strength
Face-to-face measures assessing aerobic fitness, muscular strength and ambulation
were completed on a sub-group of participants to examine the feasibility of conducting
face-to-face testing as part of the trial design and to understand preliminary efficacy of the
ExerciseGuide intervention on physical function and muscular strength. Selection was based
on proximity to the University of South Australia testing site (Adelaide). Aerobic fitness
was measured with the time taken (seconds) to complete a 400-m walk (on a 20-m track) [8].
The timed up-and-go test (3 m track) and the repeated chair stand (5 repetitions) were
measured by time to completion to provide physical functioning scores [55,56]. Tests were
performed in triplicate (except 400 m) with recovery time between trials. Dynamic muscle
strength was assessed with the one-repetition maximum method. The leg extension and
chest press exercises were used to determine lower and upper limb strength, respectively.
Patients with proximal femur bone lesions were excluded from the leg extension onerepetition maximum test. Those with rib, thoracic spine and humerus lesions were excluded
from the chest press one-repetition maximum test [8].
2.6.5. Trial Feasibility
Feasibility was evaluated using screening, recruitment and attrition data, as well
as the proportion of participants with complete data for each outcome measure. As an
approximate representation of intervention delivery expense, the time taken to deliver
coaching sessions and respond to questions was collected.
2.7. Sample Size
The target sample size for this study was 66. This sample size was considered sufficient,
based on previous similar pilot studies to reasonably estimate performance against our prespecified criteria for success [57,58]. A more detailed overview of sample size determination
is provided in the study protocol [21].
2.8. Data Analysis
Study data was analysed using SPSS version 26 (IBM, Chicago, IL, USA). Descriptive
statistics were calculated for all outcome measures by study arm and were expressed as
means and standard deviations and as medians and range if the distribution was skewed.
Categorical data was presented as a frequency (percentage). Efficacy outcome measures
were compared between groups using analysis of covariance (ANCOVA) where baseline
values and treatment status were the covariates. In all analyses residual distributional
assumptions were checked and if appeared violated, the data was natural log transformed.
Randomised participants were analysed in the group they were allocated to. All analyses
were performed with complete cases. Significance was set at 0.05 two-sided and no
adjustments were made for multiple testing. Qualitative data from open-ended questions
were analysed for common themes as well as feedback for intervention refinement.
3. Results
3.1. Participants
Participant flow through the study is outlined in Figure 2. A total of 141 individuals
screened themselves for eligibility on the ExerciseGuide website or were directly contacted
and were screened by a researcher (HELE) over the 12-month period (scheduled date of
closure). Of that, 41 eligible participants provided written informed consent, and medical
clearance (with any metastasis locations listed) and 40 were then randomised to either the
control group (n = 20) or intervention group (n = 20). One participant withdrew before
finishing the baseline testing, and two participants withdrew during the intervention, as
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finishing the baseline testing, and two participants withdrew during the intervention, as
explained in Figure 3. The prespecified recruitment goal of 66
66 was
was not
not met.
met. Participant
Participant
characteristics
ofof
7070
± 8.5
years,
all
characteristics are
are presented
presented in
inTable
Table 1.1.Participants
Participantshad
hada amean
meanage
age
± 8.5
years,
identified
as male
andand
were
approximately
3 ±3 3±years
since
metastatic
prostate
cancer
all identified
as male
were
approximately
3 years
since
metastatic
prostate
cancer diagnosis.
greater
metastasis,
a majority
diagnosis.
OverOver
80% 80%
had had
greater
thanthan
one one
bonebone
metastasis,
a majority
(93%)(93%)
werewere
curcurrently
undergoing
androgen
deprivation
therapy,
approximately
underrently
undergoing
androgen
deprivation
therapy,
andand
approximately
half half
had had
undergone
gone chemotherapy
and radiotherapy
At baseline,
participants
completed
chemotherapy
(56%) (56%)
and radiotherapy
(46%).(46%).
At baseline,
participants
completed
241.5 ±
241.5 ±
154.7
min of moderate-to-vigorous
perand
week
1.3sessions
± 1.9 ses154.7
min
of moderate-to-vigorous
physicalphysical
activityactivity
per week
1.3and
± 1.9
of
sions of resistance
training
week
(total± of
12.4
± per
19.1week
min per
a rate of
resistance
training per
weekper
(total
of 12.4
19.1
min
and week
a rateand
of perceived
perceived
exertion ofexertion
0.5 ± 0.9.of 0.5 ± 0.9.

Figure 2.
2. Participant
Participant flow
flow chart.
chart.
Figure

Radiotherapy
9 (45.0%)
10 (47.6%)
Chemotherapy
9 (45.0%)
14 (66.7%)
Hormone therapy
1 (5.0%)
1 (5.0%)
Current PSA, mean ± SD,
15.2 ± 31.9
10.2 ± 38.7
Time since metastatic disease diagnosis, mean ± SD, years
3.5 ± 3.1
2.57 ± 3.1
Number
15 (75.0%)
18 (85.7%)
Cancers 2021, 13,
5925 of individuals with ≥1 bone lesion, N (%)
Number of co-morbidities, mean ± SD
1.5 ± 1.6
2.0 ± 1.6
Abbreviations: SD, standard deviations; N, number; PSA, prostate specific androgen.

19 (46.3%)
23 (56.1%)
2 (9.5%)
12.5 ± 35.2
3.0 ± 3.1
33 (80.5%)
1.7 ± 1.6

Previous treatment, N (%)

100

4.0

90

3.5

Mean logins per week

Time on site per week (mins)

80
70
60
50
40
30
20

10 of 22

3.0
2.5
2.0
1.5
1.0
0.5

10

0.0

0
Wk 1 Wk 2 Wk 3 Wk 4 Wk 5 Wk 6 Wk 7 Wk 8

Wk 1

Wk 2

Wk 3

Wk 4

Wk 5

Wk 6

Wk 7

Wk 8

Week

Week

(a)

(b)

Figure
3. Website
usage
in the
ExerciseGuideintervention
intervention group:
group: (a)
perper
week
andand
(b) number
of of
Figure
3. Website
usage
in the
ExerciseGuide
(a)time
timespent
spentononwebsite
website
week
(b) number
per week.
loginslogins
per week.

Table 1. Participant characteristics for the whole sample at baseline (N = 40).
Characteristics

Intervention
N = 20

Control
N = 20

Total
N = 40

Age, mean ± SD, year

69.5 ± 6.6

70.8 ± 10.2

70.2 ± 8.5

Weight, mean ± SD, kg

95.9 ± 20.8

90.0 ± 17.1

92.9 ± 19.0

kg/m2

30.5 ± 5.2

28.7 ± 5.2

29.6 ± 5.3

Marital status, N (%)

Married/de facto
Widowed
Separated
Single

15 (75.5%)
1 (5.0%)
4 (20.0%)
0 (0.0%)

13 (61.9%)
2 (9.5%)
2 (9.5%)
4 (19.0%)

28 (68.3%)
3 (7.3%)
6 (14.6%)
4 (9.8%)

Location, N (%)

Major city
Inner regional
Outer regional
Remote or very remote

12 (60.0%)
5 (25.0%)
1 (5.0%)
2 (10.0%)

14 (66.7%)
4 (19.0%)
3 (14.3%)
0 (0.0%)

26 (63.4%)
9 (22.0%)
4 (9.8%)
2 (4.8%)

Education, N (%)

Secondary School
Trade/TAFE
University/Other Tertiary

2 (10.0%)
11 (55.0%)
7 (35.0%)

8 (38.1%)
5 (23.8%)
8 (38.1%)

10 (24.4%)
16 (39.0%)
15 (36.6%)

Employment, N (%)

Employed full-time
Employed part-time
Self-employed
Unemployed
Retired

1 (5.0%)
1 (5.0%)
0.0 (0%)
2 (10.0%)
16 (80.0%)

2 (9.5%)
2 (9.5%)
3 (14.3%)
1 (4.8%)
13 (61.9%)

3 (7.3%)
3 (7.3%)
3 (7.3%)
3 (7.3%)
29 (70.8%)

Current treatment, N (%)

Surgery
Radiotherapy
Chemotherapy
Hormone therapy

0 (0.0%)
2 (10.0%)
6 (30.0%)
19 (90.0%)

0 (0.0%)
2 (9.5%)
7 (9.5%)
19 (90.5%)

0 (0.0%)
4 (9.8%)
13 (31.7%)
38 (92.7%)

Previous treatment, N (%)

Surgery
Radiotherapy
Chemotherapy
Hormone therapy

8 (40.0%)
9 (45.0%)
9 (45.0%)
1 (5.0%)

5 (23.8%)
10 (47.6%)
14 (66.7%)
1 (5.0%)

13 (31.7%)
19 (46.3%)
23 (56.1%)
2 (9.5%)

Current PSA, mean ± SD,

15.2 ± 31.9

10.2 ± 38.7

12.5 ± 35.2

Time since metastatic disease diagnosis, mean ± SD, years

3.5 ± 3.1

2.57 ± 3.1

3.0 ± 3.1

Number of individuals with ≥1 bone lesion, N (%)
Number of co-morbidities, mean ± SD

15 (75.0%)
1.5 ± 1.6

18 (85.7%)
2.0 ± 1.6

33 (80.5%)
1.7 ± 1.6

Body Mass Index, mean ± SD,

Abbreviations: SD, standard deviations; N, number; PSA, prostate specific androgen.
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3.2. Intervention Acceptability
The median score of the CSQ-8 was 28.0 (range = 16–31) out of 32, indicating a high
level of intervention satisfaction and was above the pre-defined cut-points for success (i.e.,
≥20). The system usability scale mean score was 67.0 ± 15.1 out of 100, which is one point
under the pre-defined cut-point of 68 out of 100 (see Figure S1 for more detail). The overall
median score of the perceived environmental supportiveness scale (PESS) was 6.5 out of 7.0
(range = 4.3–7.0). The subscores of the PESS, autonomy, structure and involvement were
rated as 6.2 (range = 4.3–7.0), 6.6 (range = 3.2–7.0) and 6.2 (range = 4.6–7.0), respectively, out
of 7. Website perceived relevance was high, with a score of 6.0 out of 7.0 (range = 1.7–7.0).
Lastly, the individual module star ratings ranged from 3 to 4.5 out of 5, which is above
average except for tracking modules 2 and 3 (Table 2).
Table 2. ExerciseGuide website usage within the intervention group (N = 20).

Module Name

Percentage of
Modules Viewed

Average Total Time in
Module per Participant
(mins)
(M)
(SD)

(%)

(N)

Introduction

100%

20

2.4

Exercise plan (Week 1–3)

100%

20

Exercise plan (Week 4–8)

65%

Exercise benefits

Average Total
Page Views

Star Ratings

(M)

(SD)

(Median) (Range)

(N)

2.3

6.7

4.5

Nil

Nil

0

19.5

21.0

18.9

13.4

4.0

4.0–4.0

3

13

5.2

6.0

5.7

6.0

3.0

3.0–3.0

1

75%

15

2.0

1.0

3.7

2.5

4.0

4.0–5.0

4

Exercise safely

60%

12

4.0

3.0

1.5

1.5

4.5

4.0–5.0

6

Make it last

55%

11

1.5

1.3

2.0

2.2

4.0

4.0–5.0

3

Exercise+ (lifestyle)

50%

10

4.3

3.4

1.3

1.6

4.0

4.0–4.0

2

Extra help

45%

9

1.3

1.3

1.2

1.4

4.0

4.0–5.0

3

Weekly tracking module 1

65%

13

3.1

2.2

3.0

2.7

3.0

1.0–5.0

5

Weekly tracking module 2

25%

5

2.0

1.1

0.7

1.2

2.5

2.0–3.0

2

Weekly tracking module 3

10%

2

1.2

1.1

0.2

0.7

2.0

4.0–4.0

4

Racking modules were available weekly. Tracking modules 4–8 were completed by 0% (N = 0) of the ExerciseGuide intervention
group.Abbreviations: N, number; M, mean; SD, standard deviations.

Eighteen participants from the ExerciseGuide group provided written feedback regarding the intervention in the follow-up questionnaire. The support provided by the
intervention and exercise physiologist was seen as a highlight by half of the participants
(N = 9) and the structure of the program was noted as a positive by six participants, with
comments including “the program got me out of the chair with definite plan in mind” and
“the program is very structured, there is lots of information on how and why to exercise”.
Constructive feedback included lack of exercise prescription variety and boredom (N = 4),
navigation and usability issues (N = 3) and inability to adhere to the program (N = 3).
Finally, potential improvements suggested by participants included ability to autogenerate
multiple programs for diversity or increase the range of exercises (N = 4), increased personalised support from the exercise physiologist (N = 3) by increasing “regular contact” to
help increase both adherence and supervision. See Tables S1–S3 for more detailed feedback.
3.3. Usage: Behavioural Outcomes Relating to Engagement
3.3.1. Website Usage
ExerciseGuide participants spent an average of 93.3 ± 101.6 min (range = 4.3–373.6) on
the site over the eight-week period. Participants logged into the website 6.1 ± 5.9 times
(range 1–22) over the intervention. Weekly logins were highest in week one and week three,
as seen in Figure 3.
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3.3.2. Website Modules Completed
The percentage of participants who viewed each module is shown in Table 2. There
was a 100% (n = 20) completion rate in the Getting Started and Exercise Plan 1 (week
1–3) modules. The remaining modules had moderate competition rates, ranging from
45% for the Extra Help module to 75% for the Exercise Benefits module. There was a
decrease in completing tracking modules over time (65% started the tracking module, 10%
progressed through to week three of tracking and 0% completed the tracking module). The
library function was used by 50% of the ExerciseGuide group, with an average usage time
of 5.3 ± 6.4 min. Only one participant used the “Ask an Expert” feature.
3.3.3. Self-Reported Adherence to Exercise Prescription
The exercise diary was completed and returned by 89% (N = 17) of the intervention
group. The diaries indicated that participants had a self-reported resistance training
session attendance (sessions completed divided by sessions prescribed) 64.6 ± 40.2% and
aerobic training session attendance of 102 ± 62.7%. The self-reported volume adherence in
resistance training (total sets × total repetitions prescribed per session) was 78.3 ± 77.9%
and 91.5 ± 56.5% in aerobic training (total time prescribed per session). The perceived
exercise intensity was reported as 6.6 ± 0.9 out of 10 in the resistance exercise sessions and
6.6 ± 1.1 out of 10 in aerobic sessions. In terms of self-perceived adherence, participants
rated their adherence to their aerobic exercise program as 6.1 ± 3.3 out of 10 and 5.4 ± 3.8
out of 10 for their resistance training at follow-up.
3.3.4. Telehealth Consults and Time
In week one, the mean telehealth consult time per participant was 25.15 ± 7.80 min.
Telehealth mode varied; 50% of participants requested a Zoom call (N = 10), 40% of
participants favoured a phone call (N = 8) and 5% used Skype (N = 1). The mean consult
time for the week four telehealth consult was 23.92 ± 7.47 min. One participant switched
from zoom to a phone consultation, and one participant withdrew from the study. One
participant chose not to engage in the consultations due to time limitations.
Over the intervention, the exercise physiologist sent 65 text messages and 81 emails
to support participants. Furthermore, 11 phone calls were completed throughout the
intervention when participants requested or if participants did not reply to more than two
messages in a row. The mean call time per participant was 11.50 ± 8.46 min, and the total
call time per participant was 92.38 ± 8.43 min.
3.4. Safety
On follow-up, 85% of participants reported no (grade zero) bone pain (N = 16), 10%
reported mild (grade one) bone pain (N = 2), and 5% reported moderate (grade two) bone
pain resulting from the intervention (N = 1) (see Table S4). There were no grade three/lifethreatening or serious adverse events resulting from participating in the ExerciseGuide
intervention and as such met the criteria for success. The self-reported exercise diaries
showed a severity of bone pain post resistance exercise of 0.3 ± 0.8 out of 10, with a
0.0 ± 0.2 change from pre-exercise levels. The severity of bone pain post aerobic exercise
was 0.4 ± 0.8 with a 0.1 ± 0.2 increase from pre-exercise levels. Participants also reported
non-bone pain post resistance exercise of 0.7 ± 0.9 and non-bone pain post aerobic exercise
of 0.6 ± 0.9.
3.5. Efficacy
3.5.1. Physical Activity
Between-group differences for all physical activity-related outcomes are presented in
Table 3. In brief, accelerometer assessed moderate-to-vigorous physical activity (MVPA)
differed between groups at follow-up by 10.0 min per day (95% CI = (1.3, 18.6); p = 0.01) in
the ExerciseGuide group compared to the control. An increase observed in the ExerciseGuide
group, and a reduction observed in activity per day in the control group accounted for
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this difference. The adjusted mean difference per day is sufficient to meet our efficacy
criteria. When assessing weekly physical activity, accelerometry data showed a group
difference of 69.9 min in favour of the intervention group compared to the control (95%
CI = (15.1, 124.8); p = 0.01). No changes were seen in light or vigorous physical activity
or sedentary activity (Table 3). Step count also differed between groups (p = 0.02). Selfreported exercise values did not differ significantly between groups at follow-up; however,
resistance training duration (mins) increased by 10.3 min between groups at follow-up in
favour of the intervention group and this change was borderline not significant.
Table 3. Group differences in physical activity measures over the course of the intervention.
Outcome
MVPA (min/day)
Sedentary activity (min/day)

Baseline

Follow-Up

Adjusted Mean
Differences
M (95% CI)

p-Value

EG (N = 20)

CON (N = 20)

EG (N = 19)

CON (N = 19)

30.57 ± 22.0

38.4 ± 22.2

35.1 ± 23.6

32.0 ± 22.7

10.0 (1.3, 18.6)

0.01 *

731.0 ± 66.5

−33.46 (−95.0,
28.1)

0.63

668.1 ± 171.0

708.7 ± 66.5

693.6 ± 117.1

Steps (steps/day)

4977 ± 3146

6169 ± 3001

5885 ± 3071

5556 ± 3141

1332 (159, 2505)

0.02 *

Light PA (min/week)
Moderate PA (min/week)
Vigorous PA (min/week)

469.5 ± 206.9
203.0 ± 149.7
11.0 ± 14.1

561.6 ± 159.8
256.9 ± 150.0
13.4 ± 13.3

544.9 ±230.4
232.7 ± 158.8
12.0 ± 16.0

526.2 ± 199.3
208.6 ± 142.3
15.6 ± 21.1

96.7 (−5.4, 198.8)
69.9 (15.1, 124.8)
1.9 (−12.4, 8.5)

0.10
0.01 *
0.88

GLTEQ (aerobic)

37.9 ± 37.7

40.6 ± 29.2

52.3 ± 38.8

36.7 ± 28.0

16.9 (−0.5, 33.8)

0.07

Resistance training frequency
(sessions/week)
Resistance training duration (min)
Resistance training RPE

1.4 ± 2.0

1.2 ± 1.8

2.3 ± 3.6

1.8 ± 2.0

0.5 (−0.8, 1.6)

0.90

10.8 ± 17.9
0.4 ± 0.8

14.0 ± 20.3
0.6 ±0.1

22.4 ± 18.2
6.2 ± 18.9

12.5 ± 17.3
4.2 ± 3.0

10.3 (−1.2, 21.7)
2.1 (0–0.4, 3.9)

0.08
0.13

Abbreviations: EG, ExerciseGuide group; CON, Control group; PA, Physical activity; GLTEQ, Godin leisure time questionnaire; RPE, rate of
perceived exertion. * Indicates significant values (p < 0.05).

3.5.2. Computer-Tailored Individualised Exercise Prescription
Based on the data provided by participants, the ExerciseGuide resistance exercise programming for weeks 1–3 resulted in a mean frequency of 2.0 ± 0.0 sessions per week,
and 6.4 ± 1.7 (range = 4–8) exercises prescribed per person. Overall, an RPE of six out
of ten was prescribed for 68% of participants and seven out of ten for 32% of participants. The average weekly resistance exercise volume (total sets × total repetitions) was
1001.7 ± 291.0 units. The exercises prescribed are shown in the Table S5. The individualised aerobic programming in weeks 1–3 prescribed an average of 2.5 ± 0.5 sessions per
week and a mean duration of 28.3 ± 4.9 (range = 10–36) minutes per session. An RPE of
six out of ten was prescribed for fourteen participants (74%) and seven out of ten for five
(26%) participants. A summary of the aerobic modes and flexibility exercises prescribed
are shown in Tables S6 and S7).
At the end of week three, self-reported responses to questions allowed for total exercise
volume modifications based on reported compliance. In weeks 4–8 (exercise plan 2 module),
the resistance algorithm prescribed 6.3 ± 1.8 (range = 4–8) exercises per person, and the
rate of perceived exertion prescription did not change. The average session frequency per
week increased to 2.5 ± 0.3, and the average weekly resistance exercise volume (total sets
× total reps) was 1358 ± 515 units. The exercise plan 2 module prescribed 2.7 ± 0.5 aerobic
sessions for weeks 4–8, 27.7 ± 7.6 min per session and one participant’s rate of perceived
exertion changed from six to seven out of ten.
3.6. Secondary Outcomes
3.6.1. Patient-Reported Outcomes
When controlling for baseline and active treatment, there were no differences detected
between groups at follow-up in self-reported quality of life (p = 0.22–0.86), see Table 4.
Whilst not statistically significant, the reduction in fatigue levels (5.3; 95% CI = (−0.4, 11.1);
p = 0.06) and depression levels (−1.3; 95% CI = (−2.4–−2.4); p = 0.06) reported in the
intervention relative to the control may be clinically relevant [47,59]. Lastly, over time,
there were no statistical differences in sleep quality and anxiety between the ExerciseGuide
and control groups.
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Table 4. Group differences in patient-reported outcome measures over the course of the intervention.
Baseline

Follow-Up

Mean Difference

p-Value

Outcome

EG
(N = 20)

Global Health status 1
Functional status 2
Physical functioning
Role functioning
Emotional functioning
Cognitive functioning
Social functioning
Symptom Scales 3
Fatigue
Nausea/Vomiting
Insomnia
Pain
Dyspnoea
Appetite loss
Diarrhoea
Constipation
Financial difficulties

62.7 ± 22.3

Quality of life (EORTC QLQ-C30)
71.9 ± 15.0
68.4 ± 22.0
64.5 ± 22.2

9.3 (−3.7–22.4)

0.24

84.1 ± 16.2
84.2 ± 22.5
86.8 ± 10.9
77.2 ± 18.6
78.9 ± 22.1

90.9 ± 12.0
82.5 ± 18.0
86.4 ± 16.2
85.1 ± 13.5
74.6 ± 21.1

85.9 ± 17.4
82.5 ± 26.9
84.6 ± 13.4
77.2 ± 18.6
80.7 ± 21.7

87.0 ± 12.5
75.4 ± 28.5
84.2 ± 18.4
81.6 ± 12.5
70.2 ± 27.0

4.1 (−2.8–10.9)
5.2 (−10.6–21.0)
−0.2 (−8.1–7.6)
0.3 (−9.3–9.8)
8.4 (−5.7–22.6)

0.44
0.37
0.86
0.81
0.63

36.3 ± 20.2
3.5 ± 11.9
36.8 ± 27.0
21.1 ± 24.7
14.0 ± 16.9
10.5 ± 15.9
3.5 ± 15.3
3.5 ± 10.5
15.8 ± 23.2

31.6 ± 21.7
1.8 ± 7.6
24.6 ± 24.4
14.9 ± 19.2
15.8 ± 17.1
1.8 ± 7.6
5.3 ± 13.0
8.8 ± 18.7
10.5 ± 19.4

39.8 ± 19.4
0.9 ± 3.8
36.8 ± 6.7
24.6 ± 25.1
15.8 ± 20.4
5.3 ± 16.7
5.2 ± 12.5
7.0 ± 23.8
7.1 ± 17.8

38.0 ± 23.0
3.5 ± 8.9
29.8 ± 29.2
21.9 ± 26.7
19.3 ± 16.9
12.8 ± 27.7
13.0 ± 20.3
3.5 ± 10.5
14.0 ± 27.9

2.5 (−7.2–12.2)
−3.4 (−7.6–0.9)
−1.3 (−13.9–26.2)
−0.5 (−15.5–14.5)
−2.6 (−14.4–9.2)
−11.7 (−27.5–27.5)
−7.7 (−19.0–3.5)
0.5 (−1.0–2.0)
−9.6 (−23.9–4.6)

0.56
0.22
0.27
0.81
0.40
0.18
0.22
0.49
0.26

Fatigue (FACIT-F) 4

37.7 9.6

41.4 ± 6.5

38.4 ± 15.0

37.9 ± 12.4

5.3 (−0.4–11.1)

0.06

Depression (HADS-D) 5
Anxiety (HADS-A) 5

3.3 ± 3.1
2.9 ± 3.2

2.9 ± 1.9
4.4 ± 2.7

3.1 ± 2.8
3.2 ± 3.4

4.1 ± 2.3
4.7 ± 3.3

−1.3 (−2.4–−2.4)
−0.2 (−1.7–1.2)

0.06
0.74

Sleep Index (PSQI) 6

7.2 ± 2.9

6.9 ± 3.3

11.5 ± 3.7

10.7 ± 3.1

0.6 (−1.4–2.6)

0.10

CON
(N = 20)

EG
(N = 19)

CON
(N = 19)

M (95% CI)

1

2

Global health status/quality of life score ranged from 0–100, with a higher score representing a higher quality of life. Scores for the
functional scales ranged from 0–100, with a higher score representing a high level of functioning. 3 Scores for the symptom item ranged
from 0–100, and a higher score represents a higher level of symptomatology/problems. 4 FACIT-fatigue, all items were summed to create
a single fatigue score ranging from 0 to 52, with higher scores representing better functioning or less fatigue. 5 Hospital anxiety and
depression scale score provides two subscale scores (HADS-D) and (HADS-A). A score greater than seven denotes anxiety or depression. 6
The PSQI total score can range from 0 to 21. A global score of five or more indicates poor sleep quality, the higher the score, the worse the
sleep quality. Abbreviations: EG, ExerciseGuide group; CON, Control group.

3.6.2. Mechanisms of Action
Changes in social cognitive determinants of exercise between groups adjusted for
baseline and active treatment are presented in Table 5. Barrier self-efficacy was lower among
ExerciseGuide group participants compared to control group participants for both aerobic
(−3.9; 95% CI = (−8.2, 0.3); p = 0.07) and resistance training (−3.50; 95% CI = (−10.7, 2.3);
p = 0.08) at follow-up. This finding was borderline not significant. There were positive
effects on motivation type with greater identified regulation (i.e., driven by exercise being
seen as personally important) observed in the intervention group relative to the control
at follow-up. However, the mean difference was relatively small (0.4; 95% CI = (0.0, 0.7);
p = 0.04). There was also a trend showing greater intrinsic motivation (motivated by
exercise being inherently satisfying) in the intervention group in comparison to the control
group. This difference was also relatively small (0.3; 95% CI = (0.0, 0.7); p = 0.07).
3.7. Sub-Group (Physical Function and Muscular Strength Measures)
In total, 27.5% (N = 11) of the total participant group were eligible to complete the
subgroup measures prior to group randomisation. Of that, 90.9% agreed to participate
in had been randomised into the intervention group, and four were randomised into the
control group. Despite the very small sample size, there was a significant difference in
400 m walk time favouring the intervention group when comparing baseline to follow-up
(0.8 min; 95% CI = −1.5, −0.1; p = 0.02). A significant mean difference of 8.5 kg, 95%
CI = 0.9, 16.0, p = 0.04 was also seen in the one-repetition maximum chest press. This
difference is clinically meaningful [60]. No other significant differences were observed
between groups over the 8-week intervention (see Table S8).
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Table 5. Differences in mechanisms of action by group at baseline and follow-up (N = 40).
Baseline

Follow-Up
EG
CON
(N = 19)
(N = 19)

Adjusted Change
Mean Difference (95%
CI)

p-Value

36.3 ± 5.7
36.5 ± 5.2

−3.9 (−8.2, 0.3)
−3.50 (−10.7, 2.3)

0.07
0.08

Outcome expectations 2
31.4 ± 4.3
32.3 ± 4.5

31.7 ± 3.5

0.23 (−1.5, 2.0)

0.79

0.6 ± 0.7
0.9 ± 0.9
1.6 ± 1.2
2.6 ± 0.7
2.0 ± 1.1

Motivation type 3
0.4 ± 0.8
0.3 ± 0.7
0.9 ± 1.0
0.6 ± 0.6
1.9 ± 1.2
1.5 ± 1.0
3.1 ± 0.7
2.8 ± 0.7
2.7 ± 0.8
2.3 ± 0.9

0.4 ± 0.5
0.8 ± 1.0
1.9 ± 1.3
2.9 ± 0.9
2.5 ± 0.8

−0.1 (−0.5, 0.2)
−0.1 (−0.6, 0.3)
−0.1 (−0.6, 0.5
0.4 (0.0, 0.7)
0.3 (0.0, 0.7)

0.40
0.54
0.59
0.04 *
0.07

7.7 ± 2.3

6.7 ± 2.6

Social support 4
6.9 ± 2.2

7.4 ± 2.1

−1.0 (−2.5, 0.3)

0.14

68.4 ± 19.3
67.3 ± 25.9

−7.2 (−20.8, 6.4)
−14.7 (−30.5, 1.1)

0.29
0.06

Outcome

EG
(N = 20)

CON
(N = 20)

Barrier (aerobic) sum
Barrier (resistance) sum

36.2 ± 8.6
35.6 ± 8.6

36.7 ± 6.7
35.8 ± 6.7

Sum

31.9 ± 4.0

Amotivation
External regulation
Introjected regulation
Identified regulation
Intrinsic regulation
Sum

Self-efficacy 1
33.5 ± 8.7
33.1 ± 7.7

5

67.7 ± 22.3
66.6 ± 37.7

Intention
62.4 ± 27.7
54.8 ± 30.6

Aerobic intention strength
Resistance intention strength

68.2 ± 27.1
64.8 ± 31.9

Aerobic training experience 6
Resistance training experience 6
Falls confidence 7

2.5 ± 1.3
1.7 ± 1.4
3.0 ± 0.7

Behavioural capability
3.4 ± 0.8
3.0 ± 1.0
2.1 ± 1.3
1.7 ± 1.3
3.0 ± 1.1
2.9 ± 1.2

3.2 ± 0.9
1.8 ± 1.4
2.9 ± 1.1

0.2 (−0.4, 0.8)
0.2 (−0.3, 0.9)
0.0 (−1.1, 0.4)

0.47
0.37
0.39

Sum

12.9 ± 6.3

Habit formation 8
16.8 ± 6.1
13.8 ± 6.7

17.1 ± 6.1

−1.2 (−4.9, 2.3)

0.47

1

Barrier self-efficacy consisted of nine items which were scored from one (not very confident at all) to five (very confident) and the barrier
self-efficacy sum is the summation of all nine item scores (ranging from 5–45). 2 Outcome expectation consisted of eight items which were
scored from one (strongly disagree) to five (strongly agree) and outcome expectation sum is the summation of all eight item scores (ranging
from 5–40). 3 Motivation type was determined by the Behavioural Regulations in Exercise Questionnaire (BREQ). Items were scored from
one (not true for me) to five (very true for me). The mean score was calculated for every sub-item and scores range from 0–5. 4 Social
support was the summation of two items (ranging from 2–14), which were scored from one (strongly disagree) to seven (strongly agree). 5
Intention was determined on a scale of 0 (no intention to exercise) to 100 (full intention to exercise). 6 Exercise experience for both aerobic
and resistance training was scored on a scale of one (not true for me) to five (very true for me). 7 Confidence of not falling within the next
12 months was scored on a scale of one (not true for me) to five (very true for me). 8 Habit formation consisted of four items which were
from one (strongly disagree) to five (strongly agree) and the habit formation sum is the summation of all four item scores (ranging from
5–20). * Indicates significant values (p < 0.05).

4. Discussion
This study examined the acceptability, safety and preliminary efficacy of ExerciseGuide
to determine if progression to a larger scale trial is merited. There were four important
findings: (1) three of the four (acceptability, safety and meaningful moderate-to-vigorous
physical activity participation) pre-specified criteria for intervention success were achieved;
(2) intervention usability was just below criteria despite a high level of online engagement;
(3) findings for the mechanisms of action were mixed; (4) criteria for trial feasibility were
met except for recruitment.
The high levels of intervention acceptability observed in this pilot study are encouraging. While our sample likely suffers from some self-selection bias, it is notable that our
study population is inclusive of older adults and others often perceived to have difficulties
accessing online programs (e.g., those living in remote Australia) [61]. It is also notable
that positive results were observed across multiple facets of acceptability, including those
associated with uptake and efficacy (e.g., relevance) [37,62]. Of exception, intervention
usability was deemed marginal, scoring 67.0 ± 15.1 out of 100. The score was one point
under the pre-specified cut point for success, suggesting that the ExerciseGuide website
performed just at or below average compared to industry standards. Similar scores have
been observed in evaluations of other web-based physical activity websites in similar populations. Alley et al. reported a usability score of 62.9 ± 10.2 in a study evaluating a tailored
website with interactive features for older Australian adults [63]. Finlay et al. compared
usability of a computer-tailored website among Australian men with localised prostate
cancer set up to deliver modules either in a free choice scenario (similar to ExerciseGuide) or
a tunnelled scenario where a new module was unlocked each week. Average usability was
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higher in the tunnelled intervention 67.4 ± 14.6 compared to the free choice intervention
56.4 ± 12.2 [63,64], but as in the current study the score was marginal. Usability testing
and iterative refinement was undertaken with ExerciseGuide in a small lab-based study to
enhance usability with some success [17]. However, given, that usability is likely to affect
the uptake and continued use of web-based tools additional strategies should be considered, including implementation of feedback from pilot study participants [65]. Findings in
the Finlay study and qualitative feedback from two ExerciseGuide participants consider that
usability may improve if participants are navigated through future interventions [64]. This
may also lead to increased usage of education modules which were not accessed as often
as the exercise prescription modules in the current study. Lastly, further revision to the
exercise prescription component of the intervention may improve the acceptability of the
intervention. Real world usability testing with iterative changes may be useful to ensure
the changes are positive.
Prior to the study, another unknown aspect was the safety of a distance-based exercise
prescription tool in individuals with metastatic prostate cancer. The current study reported
zero serious adverse events (≥3 CTCAE grading criteria) and twelve study-related grade
one events (increased muscular or joint soreness and acute fatigue levels). A recent systematic review in individuals with bone metastases supports the use of unsupervised
exercise as long as there is a supervised component, including face-to-face exercise instruction [66]. The novel use of distance-based supervision may provide another safe method of
instruction by qualified practitioners.
In terms of preliminary efficacy, the ExerciseGuide intervention resulted in additional
10.0 min (95% CI = (1.3, 18.6); p = 0.01) of moderate-to-vigorous physical activity minutes
per day compared to the wait-list control group, which equates to 70 min per week. Our
results are moderately higher than other web-based studies that included individuals with
metastatic prostate cancer, including Trinh et al., who showed a 44.1 min (11.1 to 77.0)
improvement over 12 weeks and Golsteijn et al. reported a raw score change of 60 min
within the OncoActive intervention [15,67]. The additional physical activity increase
observed in the current study may be due to increased individualised support through
telehealth consults or multi-modal exercise prescription tailored to individuals’ current
level of physical activity and metastases/injury locations, which were not available in the
Trihn et al. or Golsteijn et al. studies. Although it is important to note that the current study
was only eight weeks in duration, it is unknown what effect increased intervention length
may have on key factors such as moderate-to-vigorous physical activity, physical fitness,
fatigue and depression. There is limited research on optimal duration to see significant
changes in this population and further research is required.
A highlight of the current study is the measurement of changes in targeted theoretical constructs to improve understanding of why the ExerciseGuide intervention changed
moderate-to-vigorous physical activity behaviours, which can have implications for future
research. There was an increase in identified motivation in the ExerciseGuide group, which
indicates a rise in individuals performing exercise because they are driven by reasons
personally important, which may be indicative of using computer-tailoring algorithms
to provide personally relevant messages [38]. A review by Teixeira et al. examining the
association between motivation type (based on self-determination theory) and uptake and
maintenance of exercise found that increased identified motivation is associated with exercise adoption [30]. As such, ExerciseGuide may be a promising intervention for engaging
individuals with metastatic prostate cancer in exercise. However, additional strategies may
be needed to encourage exercise maintenance as there were large variations in attending
and completing prescribed exercise among participants over the 8-week intervention. The
review by Teixeira et al. suggested that it is an increase in intrinsic motivation that is
associated with longer term exercise participation. In our study, there was a positive trend,
but no significant difference compared to the control in intrinsic motivation. Strategies to
increase exercise enjoyment, such as affect regulated exercise [68] and a greater variety of
exercises may be useful.
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Previous research has also suggested that habit strength and self-efficacy are important for maintenance of exercise behaviours [29]. Our intervention did not improve habit
strength relative to the control. There was a trend towards reduced self-efficacy in the
ExerciseGuide group in comparison to the control group despite introducing behaviour
change techniques to improve self-efficacy, including allowing participants to adapt their
prescription based on perceived confidence levels, video demonstrations showing how
to perform the behaviour, psycho-education around goal-setting, planning and obtaining
further support, and by facilitating self-monitoring [26,69]. Interestingly, reductions in
self-efficacy have been seen in other web-based physical activity interventions in individuals diagnosed with cancer. Forbes et al. suggest that if participants have not recently
undertaken a physical activity regime, their personal beliefs regarding physical activity
such as ease or acute benefits may be overestimated [26]. Once they undertake the program, their beliefs may become more realistic within their current constraints [26]. Given
intrinsic motivation, habits scores and self-efficacy are predictive of long-term exercise
adherence [30], changes to the ExerciseGuide intervention may be needed to support exercise
maintenance. Evaluating behavioural determinants during the intervention and targeting
strategies to improve these constructs over time is recommended.
The difference between the self-reported aerobic and resistance adherence (102 ± 62.7%
vs. 64.6 ± 40.2%) and volume (91.5 ± 56.5% vs. 78.3 ± 77.9%) was interesting. A possible
explanation for the disparity may be due to the higher levels of aerobic exercise behaviours
at baseline. Participants may have found it easier to adhere to aerobic exercise in comparison to resistance training as it was a modality that they were already completing in
some form. Therefore, participants in distance-based exercise interventions such as ExerciseGuide may require more targeted support to develop resistance training routines, such
as increased real-time remotely supervised sessions or tools to track, prompt and reward
resistance training behaviours. Some changes to the resistance training prescription library
to increase variety may also improve adherence through increased enjoyment. Participant
qualitative feedback suggested increased variety of resistance-training exercises would be
appreciated for this reason. Another strategy that may work to increase adherence could
be providing opportunities for participants to complete their individualised program in
remotely supervised online group classes using a telehealth platform [70]. This could increase feelings of relatedness, which according to self-determination theory, would enhance
intrinsic motivation [71]. The authors conclude there is reasonable feasibility of conducting
a larger-scale trial. Pre-specified criteria were surpassed for the proportion of outcome data
collected and participant retention. The study did not meet the pre-specified criteria of
recruiting 66 participants; however, recruitment source was tracked, and lessons learned
from the trial should increase recruitment feasibility for future studies. In terms of enrolled
participants, recruitment from support groups (free), physicians (free) and paid social
media advertisements (USD 81 per person recruited) were most cost-effective. In contrast,
paid-registry recruitment was not as cost-effective (USD 800 per person recruited). We had
few physicians/hospital sites involved and increasing this would likely lead to increased
feasibility. Overall, evidence-based strategies to enhanced recruitment would be welcome.
For example, Frampton et al. recommended that future researchers embed recruitment
trials within randomised trials to help us better understand the efficacy of recruitment
strategies in terms of increasing uptake and recruiting representative samples [72].
Strengths and Limitations of the Study
The current pilot study should be interpreted within the context of key strengths
and limitations. The recruitment goal of 66 participants was not met, which may have
implications on future trial design [58]. The study was eight weeks in duration, and
there was no long-term follow-up. As such, authors could not determine whether the
intervention resulted in long term changes of key parameters such as moderate-to-vigorous
activity levels. Despite a diagnosis of metastatic cancer, participants who were reasonably
active prior to the intervention may not be representative of all individuals with metastatic
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prostate cancer. Finally, self-report measures were used for various study outcomes, such
as intervention adherence, which may introduce response biases.
A strength of the study is that the ExerciseGuide intervention was methodically developed based on behavioural theory, previously investigated exercise prescription methodology, and formative user-centred research [5,8,17]. Furthermore, the study used a randomised design and publication of the study protocol aimed to ensure transparency around
pre-specified criteria for success [21]. Lastly, the study examined different measures of
acceptability and mechanisms of action, which has provided the researchers with the
opportunity to explore what intervention components may be efficacious and improve
future intervention development.
5. Conclusions
Our findings provide preliminary evidence that a web-based tailored exercise and
behavioural change intervention designed for individuals with metastatic prostate cancer is
acceptable, safe and efficacious for improving moderate-to-vigorous activity levels, fatigue
and motivation. Given the high disease burden in this population, there is a clear need to
develop effective distance-based and scalable supportive care interventions for individuals
who are unable to access supervised interventions. As such, we consider that a large-scale
trial with an enhanced version of the intervention is justified.
Supplementary Materials: The following are available online at https://www.mdpi.com/article/10
.3390/cancers13235925/s1, Figure S1: System usability scores in the ExerciseGuide intervention, Table
S1: Written positive qualitative feedback from ExerciseGuide intervention, Table S2: Written constructive qualitative feedback from ExerciseGuide intervention, Table S3: Written thoughts for improvement
feedback from ExerciseGuide intervention, Table S4: Nonserious adverse events self-reported during
ExerciseGuide intervention, Table S5: Resistance exercise prescribed within the ExerciseGuide intervention, Table S6: Aerobic exercise prescribed and completed within the ExerciseGuide intervention,
Table S7: Flexibility exercise prescribed within the ExerciseGuide intervention, Table S8: Subgroup
physical functioning measures at baseline and follow-up (N = 10).
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